Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Akari Therapeutics Plc

NASDAQ: AKTX · Life Sciences · 4 alerts · CIK 1541157

Share price
$6.51Close, Nov 16
Shares outstanding
186.09BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Akari Therapeutics Plc filings on SEC EDGAR ↗

4:46 PM ET 8-K
Stock Plan Amendment

Akari Therapeutics Stock Plan Amendment

Akari Therapeutics held a Special General Meeting where shareholders approved an amendment to the 2023 Equity Incentive Plan. The amendment increases the number of ordinary shares available for issuance by 144 billion shares, equivalent to 1.8 million American Depositary Shares (ADSs).

4:45 PM ET 8-K
Stock Plan Amendment

Akari Therapeutics Stock Plan Amendment

Akari Therapeutics amended its agreement with CEO Abizer Gaslightwala to increase his base salary to $625,000 and his target bonus to 55%. The amendment includes a grant of 174,000 ADS options and restricted stock units, both of which are subject to shareholder approval of an amendment to the company's 2023 Equity Incentive Plan to increase the share pool.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.